Coherus BioSciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$64,979
$77,063
$91,524
$74,568
Gross Profit
35,424
40,970
5,894
41,865
EBITDA
-19,322
-34,218
-67,297
-32,006
EBIT
-20,509
-35,725
-68,360
-33,643
Net Income
-12,921
102,875
-79,653
-39,641
Net Change In Cash
64,979
77,063
91,524
74,568
Free Cash Flow
59,734
-46,766
-12,971
-54,300
Cash
159,240
259,774
102,891
80,259
Basic Shares
114,819
125,529
111,492
97,738

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$257,244
$211,042
$326,551
$475,824
Gross Profit
94,461
140,959
268,960
438,157
EBITDA
-189,408
-253,058
-264,141
156,873
EBIT
-193,199
-256,757
-269,802
151,904
Net Income
-237,892
-326,628
-306,322
132,244
Net Change In Cash
257,244
211,042
326,551
475,824
Cost of Revenue
-353,648
-123,963
363,690
Free Cash Flow
-175,170
-243,163
-38,721
147,089
Cash
102,891
63,547
417,195
541,158
Basic Shares
94,162
77,630
75,449
83,491

Earnings Calls

Quarter EPS
2024-06-30
-$0.14
2024-03-31
-$0.32
2023-12-31
-$0.62
2023-09-30
-$0.41